期刊
IMMUNITY
卷 52, 期 1, 页码 96-+出版社
CELL PRESS
DOI: 10.1016/j.immuni.2019.11.004
关键词
-
类别
资金
- Japan Society for the Promotion of Science (JSPS) KAKENHI [JP16H06387, 18H05022]
- Naito Foundation
- Kato Memorial Bioscience Foundation
- Life Science Foundation of Japan
- Uehara Memorial Foundation
- Kanae Foundation for the Promotion of Medical Science
- National Institutes of Health [AI145997, P30 DK063491]
Although type 1 innate lymphoid cells (ILC1s) have been originally found as liver-resident ILCs, their pathophysiological role in the liver remains poorly investigated. Here, we demonstrated that carbon tetrachloride (CCl4) injection into mice activated ILC1s, but not natural killer (NK) cells, in the liver. Activated ILC1s produced interferon-gamma (IFN-gamma) and protected mice from CCl4-induced acute liver injury. IFN-gamma released from activated ILC1s promoted the survival of hepatocytes through upregulation of Bcl-xL. An activating NK receptor, DNAM-1, was required for the optimal activation and IFN-gamma production of liver ILC1s. Extracellular adenosine triphosphate accelerated interleukin-12-driven IFN-gamma production by liver ILC1s. These findings suggest that ILC1s are critical for tissue protection during acute liver injury.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据